De novo determination of the crystal structure of a large drug molecule by crystal structure prediction-based powder NMR crystallography

Maria Baias, Jean Nicolas Dumez, Per H. Svensson, Staffan Schantz, Graeme M. Day, Lyndon Emsley

    Research output: Contribution to journalArticle

    Abstract

    The crystal structure of form 4 of the drug 4-[4-(2-adamantylcarbamoyl)-5- tert-butyl-pyrazol-1-yl]benzoic acid is determined using a protocol for NMR powder crystallography at natural isotopic abundance combining solid-state 1H NMR spectroscopy, crystal structure prediction, and density functional theory chemical shift calculations. This is the first example of NMR crystal structure determination for a molecular compound of previously unknown structure, and at 422 g/mol this is the largest compound to which this method has been applied so far.

    Original languageEnglish (US)
    Pages (from-to)17501-17507
    Number of pages7
    JournalJournal of the American Chemical Society
    Volume135
    Issue number46
    DOIs
    StatePublished - Nov 20 2013

    Fingerprint

    Crystallography
    Powders
    Magnetic Resonance Spectroscopy
    Crystal structure
    Nuclear magnetic resonance
    Molecules
    Pharmaceutical Preparations
    Benzoic acid
    Chemical shift
    Nuclear magnetic resonance spectroscopy
    Density functional theory
    Proton Magnetic Resonance Spectroscopy
    4-(4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl)benzoic acid

    ASJC Scopus subject areas

    • Catalysis
    • Chemistry(all)
    • Biochemistry
    • Colloid and Surface Chemistry

    Cite this

    De novo determination of the crystal structure of a large drug molecule by crystal structure prediction-based powder NMR crystallography. / Baias, Maria; Dumez, Jean Nicolas; Svensson, Per H.; Schantz, Staffan; Day, Graeme M.; Emsley, Lyndon.

    In: Journal of the American Chemical Society, Vol. 135, No. 46, 20.11.2013, p. 17501-17507.

    Research output: Contribution to journalArticle

    Baias, Maria ; Dumez, Jean Nicolas ; Svensson, Per H. ; Schantz, Staffan ; Day, Graeme M. ; Emsley, Lyndon. / De novo determination of the crystal structure of a large drug molecule by crystal structure prediction-based powder NMR crystallography. In: Journal of the American Chemical Society. 2013 ; Vol. 135, No. 46. pp. 17501-17507.
    @article{809d80ec23fd4e038587c13a152729a6,
    title = "De novo determination of the crystal structure of a large drug molecule by crystal structure prediction-based powder NMR crystallography",
    abstract = "The crystal structure of form 4 of the drug 4-[4-(2-adamantylcarbamoyl)-5- tert-butyl-pyrazol-1-yl]benzoic acid is determined using a protocol for NMR powder crystallography at natural isotopic abundance combining solid-state 1H NMR spectroscopy, crystal structure prediction, and density functional theory chemical shift calculations. This is the first example of NMR crystal structure determination for a molecular compound of previously unknown structure, and at 422 g/mol this is the largest compound to which this method has been applied so far.",
    author = "Maria Baias and Dumez, {Jean Nicolas} and Svensson, {Per H.} and Staffan Schantz and Day, {Graeme M.} and Lyndon Emsley",
    year = "2013",
    month = "11",
    day = "20",
    doi = "10.1021/ja4088874",
    language = "English (US)",
    volume = "135",
    pages = "17501--17507",
    journal = "Journal of the American Chemical Society",
    issn = "0002-7863",
    publisher = "American Chemical Society",
    number = "46",

    }

    TY - JOUR

    T1 - De novo determination of the crystal structure of a large drug molecule by crystal structure prediction-based powder NMR crystallography

    AU - Baias, Maria

    AU - Dumez, Jean Nicolas

    AU - Svensson, Per H.

    AU - Schantz, Staffan

    AU - Day, Graeme M.

    AU - Emsley, Lyndon

    PY - 2013/11/20

    Y1 - 2013/11/20

    N2 - The crystal structure of form 4 of the drug 4-[4-(2-adamantylcarbamoyl)-5- tert-butyl-pyrazol-1-yl]benzoic acid is determined using a protocol for NMR powder crystallography at natural isotopic abundance combining solid-state 1H NMR spectroscopy, crystal structure prediction, and density functional theory chemical shift calculations. This is the first example of NMR crystal structure determination for a molecular compound of previously unknown structure, and at 422 g/mol this is the largest compound to which this method has been applied so far.

    AB - The crystal structure of form 4 of the drug 4-[4-(2-adamantylcarbamoyl)-5- tert-butyl-pyrazol-1-yl]benzoic acid is determined using a protocol for NMR powder crystallography at natural isotopic abundance combining solid-state 1H NMR spectroscopy, crystal structure prediction, and density functional theory chemical shift calculations. This is the first example of NMR crystal structure determination for a molecular compound of previously unknown structure, and at 422 g/mol this is the largest compound to which this method has been applied so far.

    UR - http://www.scopus.com/inward/record.url?scp=84888338272&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84888338272&partnerID=8YFLogxK

    U2 - 10.1021/ja4088874

    DO - 10.1021/ja4088874

    M3 - Article

    VL - 135

    SP - 17501

    EP - 17507

    JO - Journal of the American Chemical Society

    JF - Journal of the American Chemical Society

    SN - 0002-7863

    IS - 46

    ER -